SEARCH

SEARCH BY CITATION

References

  • 1
    SINAN. Sistema de Informações de Agravos de Notificação. 2012. http://dtr2004.saude.gov.br/sinanweb/tabnet/tabnet?sinannet/tuberculose/bases/tubercbrnet.def
  • 2
    Fiúza de Melo FA, Afiune JB. Tuberculose, uma doença ocupacional: infecção, adoecimento e proteção dos profissionais da saúde a serviço de atenção à tuberculose. Boletim de Pneumologia Sanitária 1995;1:568.
  • 3
    Ministério da Saúde. Secretaria de Vigilância em Saúde. Programa Nacional de Controle da Tuberculose. Brasil: Ministério da Saúde, 2010. ISBN: 978-85-334-1816-5.
  • 4
    Pereira MG. Epidemiologia: teoria e prática. Rio de Janeiro Ed Guanabara Koogan, 1999. 598 p.
  • 5
    Ministério da Saúde. Manual Técnico para o controle da tuberculose. Caderno de Atenção Básica, n. 6, Brasília, Brasil: Ministério da Saúde, 2002. ISBN: 85-334-0491-3.
  • 6
    Carvalho ACC, Kritski AL, Ruffino-Netto A. Investigação dos contatos de pacientes com tuberculose pulmonar: prioridade e conduta. Pulmão 2002;11:95101.
  • 7
    World Health Organization. Global Tuberculosis Control. Geneva, Switzerland: World Health Organization, 2011. ISBN: 978-92-4-156438-0.
  • 8
    Kinjo Y, Kawakami K, Uezu K et al. Contribution of IL-18 to Th1 response and host defense against infection by Mycobacterium tuberculosis: a comparative study with IL-12p40. J Immunol 2002;169:3239.
  • 9
    Raja A. Immunology of tuberculosis. Indian J Med Res 2004;120:21332.
  • 10
    Lin PL, Flynn J. Understanding latent tuberculosis: a moving target. J Immunol 2010;185:1522.
  • 11
    Gupta A, Kaul A, Tsolaki AG, Kishore U, Bhakta S. Mycobacterium tuberculosis: immune evasion, latency and reactivation. Immunobiology 2012;217:36374.
  • 12
    Cavalcanti YVN, Pereira VRA, Reis LC et al. Evaluation of memory immune response to Mycobacterium extract among household contact of tuberculosis cases. J Clin Lab Anal 2009;23:5762.
  • 13
    Churina EG, Urazova OI, Novitskiy VV. The role of Foxp3-expressing regulatory T Cells and T helpers in immunopathogenesis of multidrug resistant pulmonary tuberculosis. Tuberc Res Treat 2012;2012:19.
  • 14
    Ribeiro-Rodrigues R, Resende CO T, Rojas R et al. A role for CD4+CD25+ T cells in regulation of response during human tuberculosis. Clin Exp Immunol 2006;144:2534.
  • 15
    Hougardy J-M, Place S, Hildebrand M et al. Regulatory T cells depress immune response to protective antigen in active tuberculosis. Am J Respir Crit Care Med 2007;176:40916.
  • 16
    Guyot-Revol V, Innes JA, Hackforth S, Hinks T, LalvaniI A. Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med 2006;173:80310.
  • 17
    Belkaid Y. Regulatory t cells and infection: a dangerous necessity. Nat Rev 2007;7:87587.
  • 18
    Wu Y, Borde M, Heissmeyer V et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 2006;126:37587.
  • 19
    Nicholson S, Bonecini-Almeida MDG, Lapa E Silva JR et al. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med 1996;183:2293302.
  • 20
    Niedbala W, Cai B, Liu H, Pitman N, Chang L, Liew FY. Nitric oxide induces CD4+CD25+ Foxp3 regulatory T cells from CD4+CD25 T cells via p53, IL-2, and OX40. Proc Natl Acad Sci USA 2007;104:547883.
  • 21
    Jonna I, Mekonnen M, Abate E et al. Resistance to first-line anti-TB drugs is associated with reduced nitric oxide susceptibility in Mycobacterium tuberculosis. PLoS ONE 2012;7:e39891. Epub 2012 Jun 29.
  • 22
    Martin IV, Bartek IL, Visconti K, Schoolnik GK. The response of Mycobacterium tuberculosis to reactive oxygen and nitrogen species. Front Microbiol 2011;2:105.
  • 23
    Read SM, Northcote DH. Minimization of variation in the response to different proteins of the Coomassie Blue G - binding assay for protein. Anal Biochem 1981;116:5364.
  • 24
    Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:6805.
  • 25
    Hibbs JBJR, Taintor R, Vavrin Z, Rachlin E. Nitric oxide: a cytotoxic activated macrophages effector molecule. Bioch Biophy Res Commun 1988;157:8794.
  • 26
    Chegou NN, Black GF, Loxton AG et al. Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting. BMC Infect Dis 2012;12:10.
  • 27
    Hesseling AC, Mandalakas AM, Kirchner HL et al. Highly discordant T cell responses in individuals with recent exposure to household tuberculosis. Thorax 2009;64:8406.
  • 28
    Chegou NN, Black GF, Kidd M, Van Helden PD, Walzl G. Host markers in Quantiferon supernatants differentiate active TB from latent TB infection: preliminary report. BMC Pulm Med 2009;9:21.
  • 29
    HarariI A, Rozot V, Enders FB et al. Dominant TNF-α+ Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease. Nat Med 2011;17:3726.
  • 30
    Lucena-Silva N, Baliza MD, Martins AE et al. Relatedness and HLA-DRB1 typing may discriminate the magnitude of the genetic susceptibility to tuberculosis using a household contact model. J Epidemiol Community Health 2010;64:5137.
  • 31
    Lin Y, Zhang M, Hofman FM, Gong J, Barnes PF. Absence of a prominent Th2 cytokine response in human tuberculosis. Infect Immun 1996;64:13516.
  • 32
    Zhang M, Lin Y, Iyer DV, Gong J, Abrams JS, Branes PF. T cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun 1995;63:32314.
  • 33
    Flynn JL, Chan J, Trielbold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993;178:224954.
  • 34
    Danvider PSD, Mustafa B, Milligton KA et al. Novel M tuberculosis antigen-specific T-cells are early markers of infection and disease progression. PLosOne 2011;6:e28754.
  • 35
    Tomioka H, Tatano Y, Sano C, Shimizu T. Development of new antituberculous drugs based on bacterial virulence factors interfering with host cytokine networks. J Infect Chemother 2011;17:30217.
  • 36
    Khader SA, Bell GK, Pearl JE et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 2007;8:36977.
  • 37
    Mohan VP, Scanga CA, YU K, Scott HM, Tanaka KE, Tsang E. Effects of tumor necrosis factor - α on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infect Immun 2001;69:184755.
  • 38
    Zuniga J, Torres-Garcia D, Santos-Mendoza T, Rodrigues-Reyna TS, Granados J, Yunis EJ Cellular and humoral mechanisms involved in the control of tuberculosis. Clin Dev Immunol 2012;2012:118.
  • 39
    Sharma PK, Saha PK, Singh A, Sharma SK, Ghosh B, Mitra DK. FOXP3+ regulatory T cells suppress effector T-cell function at pathologic site in military tuberculosis. Am J Respir Crit Care Med 2009;179:106170.
  • 40
    Campbell DJ, Ziegler SF. FOXP3 modifies the phenotypic and functional properties of regulatory T cells. Nat Rev Immunol 2007;7:30510.
  • 41
    Melo KM, Carvalho BTC. Células T regulatórias: mecanismos de ação e função nas doenças humanas. Rev Bras Aler Imunopatol 2009;32:1848.
  • 42
    Lee S-W, Choi H, Eun S-Y et al. Nitric oxide modulates TGF-β–directive signals to suppress Foxp3+ regulatory T cell differentiation and potentiate Th1 development. J Immunol 2011;186:697280.
  • 43
    Rahman S, Gudetta B, Fink J et al. Compartmentalization of immune responses in human tuberculosis: few CD8+ effector T cells but elevated levels of FoxP3+regulatory T cells in the granulomatous lesions. Am J Pathol 2009;174:221124.